These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2866616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potential of interaction between the H1-antagonist astemizole and other drugs.
    Rombaut N, Heykants J, Vanden Bussche G.
    Ann Allergy; 1986 Nov; 57(5):321-4. PubMed ID: 2877601
    [Abstract] [Full Text] [Related]

  • 5. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J, Awouters F, Neimegeers CJ, Janssens F, Van Nueten JM, Janssen PA.
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [Abstract] [Full Text] [Related]

  • 6. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1984 Jul; 28(1):38-61. PubMed ID: 6204835
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Nonsedative H1 antihistaminics].
    Blehová H, Metys J.
    Cas Lek Cesk; 1991 May 24; 130(14):436-7. PubMed ID: 1676935
    [Abstract] [Full Text] [Related]

  • 12. Mizolastine, a novel selective histamine H1 receptor antagonist: lack of sedative potential on the EEG in the rodent.
    Depoortere H, Decobert M, Granger P, Françon D.
    Neuropsychobiology; 1995 May 24; 32(4):214-21. PubMed ID: 8587704
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experimentation with a new antihistaminic molecule in allergic conjunctivitis].
    Hesse A, Reggiardo F, Satragno L, Rivara A.
    Minerva Med; 1988 Oct 24; 79(10):883-6. PubMed ID: 2903466
    [Abstract] [Full Text] [Related]

  • 15. [Astemizole: its pharmacokinetics and pharmacologic properties].
    Levron JC, Gillardin JM, Sabbah A.
    Allerg Immunol (Paris); 1990 Jun 24; 22(6):233-41. PubMed ID: 1974137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM, Janssen PF, Gommeren W, Leysen JE.
    Mol Pharmacol; 1982 Mar 24; 21(2):294-300. PubMed ID: 6124876
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of astemizol on mammary blood flow and milk composition after intramammary histamine infusion.
    Burvenich C, Peeters G.
    Arch Int Pharmacodyn Ther; 1983 Apr 24; 262(2):311-2. PubMed ID: 6135402
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.